Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Local immune tolerance induction refers to the mechanisms by which the immune system actively suppresses or limits immune responses in specific tissues or microenvironments, preventing unwanted inflammation and autoimmunity while maintaining tissue homeostasis. This process is crucial for protecting normal tissues from immune-mediated damage, especially at barrier sites such as the gut, skin, and mucosal surfaces. Key cellular players include regulatory T cells (Tregs), tolerogenic dendritic cells (DCs), and macrophages. Molecular mechanisms involve Foxp3, IL-10, IDO, retinoic acid, and the Sialic Acid–Siglec Axis. Defects in these mechanisms contribute to various diseases, making them therapeutic targets for enhancement (in autoimmunity/allergy) or breakdown (in cancer).
Modulation of immune cell activity in specific tissues or microenvironments to suppress or limit immune responses.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Local Immune Tolerance Induction.